levodopa has been researched along with Libman-Sacks Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mink, JW; Zinner, SH | 1 |
| Chacón, J; García-Moreno, JM | 1 |
| Bang, OY; Joo, US; Lee, PH; Seo, CH | 1 |
| Rodgers, KJ; Shiozawa, N | 1 |
| Orta Daniel, SJ; Ulises, RO | 1 |
| Kaizuka, M; Okumura, K; Osawa, H; Shirato, KI; Tamura, N; Tsunoda, S; Yamabe, H | 1 |
| Klawans, HL; Weiner, WJ | 1 |
| Cassi, E; Massarotti, G; Passaleva, A | 1 |
| Rowe, WS | 1 |
3 review(s) available for levodopa and Libman-Sacks Disease
| Article | Year |
|---|---|
Juvenile parkinsonism as a manifestation of systemic lupus erythematosus: case report and review of the literature.
Topics: Adult; Diagnosis, Differential; Drug Therapy, Combination; Humans; Levodopa; Lupus Erythematosus, Systemic; Lupus Vasculitis, Central Nervous System; Male; Methylprednisolone; Neurologic Examination; Parkinsonian Disorders; Prednisolone; Recurrence | 2002 |
Misincorporation of amino acid analogues into proteins by biosynthesis.
Topics: Amino Acids; Amino Acids, Diamino; Aminoacylation; Animals; Bacteria; Canavanine; Ethionine; Humans; Levodopa; Lupus Erythematosus, Systemic; Oxidation-Reduction; Parkinson Disease; Plants; Protein Biosynthesis; Tryptophan | 2008 |
The pharmacology of choreatic movement disorders.
Topics: Acetylcholine; Acute Disease; Amphetamine; Chorea; Dopamine; gamma-Aminobutyric Acid; Hepatolenticular Degeneration; Humans; Huntington Disease; Hyperthyroidism; Levodopa; Lupus Erythematosus, Systemic; Movement Disorders; Serotonin | 1976 |
6 other study(ies) available for levodopa and Libman-Sacks Disease
| Article | Year |
|---|---|
Movement disorders ii: chorea, dystonia, myoclonus, and tremor.
Topics: Child; Chorea; Dopamine Agents; Dyskinesia, Drug-Induced; Dyskinesias; Dystonia; Humans; Levodopa; Lupus Erythematosus, Systemic; Myoclonus; Tremor | 2010 |
Basal ganglia hyperperfusion in a patient with systemic lupus erythematosus-related parkinsonism.
Topics: Adult; Antiparkinson Agents; Basal Ganglia; Delirium; Epilepsy, Tonic-Clonic; Female; Hallucinations; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Levodopa; Lupus Erythematosus, Systemic; Parkinson Disease, Secondary; Prednisolone; Tomography, Emission-Computed, Single-Photon | 2004 |
Stroke of the substance nigra and parkinsonism as first manifestation of systemic lupus erythematosus.
Topics: Antiparkinson Agents; Female; Humans; Levodopa; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Middle Aged; Parkinsonian Disorders; Stroke; Substantia Nigra | 2008 |
Systemic lupus erythematosus associated with transverse myelitis and parkinsonian symptoms.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Antiparkinson Agents; Cyclophosphamide; Female; Humans; Immunosuppressive Agents; Levodopa; Lupus Erythematosus, Systemic; Myelitis; Parkinson Disease, Secondary; Ribonucleosides | 1997 |
Lupus-like autoimmune syndrome after levodopa and benserazide.
Topics: Autoimmune Diseases; Benserazide; Humans; Hydrazines; Levodopa; Lupus Erythematosus, Systemic; Male; Middle Aged; Syndrome | 1979 |
Some of the clinically more important side effects of drug therapy. Part 2.
Topics: Anticonvulsants; Antidepressive Agents, Tricyclic; Barbiturates; Carbenoxolone; Contraceptives, Oral; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Hemorrhage; Humans; Hydroxyquinolines; Levodopa; Liver; Lupus Erythematosus, Systemic; Phenothiazines; Porphyrias; Smoking; Stomach Ulcer | 1975 |